Presentation is loading. Please wait.

Presentation is loading. Please wait.

Ping Yang, MD, PhD, Andrea L. Cheville, MD, Jason A

Published byJeanne Lessard Modified over 5 years ago

Similar presentations

Presentation on theme: "Ping Yang, MD, PhD, Andrea L. Cheville, MD, Jason A"— Presentation transcript:

1 Quality of Life and Symptom Burden among Long-Term Lung Cancer Survivors 
Ping Yang, MD, PhD, Andrea L. Cheville, MD, Jason A. Wampfler, BS, Yolanda I. Garces, MD, Aminah Jatoi, MD, Matthew M. Clark, PhD, Stephen D. Cassivi, MD, David E. Midthun, MD, Randolph S. Marks, MD, Marie-Christine Aubry, MD, Scott H. Okuno, MD, Brent A. Williams, PhD, Francis C. Nichols, MD, Victor F. Trastek, MD, Hiroshi Sugimura, MD, PhD, Linda Sarna, DNSc, Mark S. Allen, MD, Claude Deschamps, MD, Jeff A. Sloan, PhD  Journal of Thoracic Oncology  Volume 7, Issue 1, Pages (January 2012) DOI: /JTO.0b013e b3e Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Mean overall QOL of LTLCS* at one to 7 years postdiagnosis. *LTLCS: 447 long-term lung cancer survivors who answered the QOL questionnaire on <3- and ≥5-year follow-ups. All scales are measured 0 (worst) to 100 (best). †p values are from profile analysis test for flatness, indicative of trend over time. Journal of Thoracic Oncology 2012 7, 64-70DOI: ( /JTO.0b013e b3e) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Subscales of survivors with declined (n = 155, A) or improved (n = 67, B) overall QOL. Journal of Thoracic Oncology 2012 7, 64-70DOI: ( /JTO.0b013e b3e) Copyright © 2012 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Ping Yang, MD, PhD, Andrea L. Cheville, MD, Jason A"

Similar presentations

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,

Lung Adenocarcinoma with Ipsilateral Breast Metastasis: A Simple Coincidence? Hsu-Ching Huang, MD, Jen-Fan Hang, MD, Mei-Han Wu, MD, Teh-Ying Chou, MD,
Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
A Hole in the Heart Journal of Thoracic Oncology

A Hole in the Heart Journal of Thoracic Oncology
Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal.

Phase II Study of Preoperative Pemetrexed, Carboplatin, and Radiation Followed by Surgery for Locally Advanced Esophageal Cancer and Gastroesophageal.
Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,

Carcinoma NOS is a Common Histologic Diagnosis and is Increasing in Proportion Among Non-small Cell Lung Cancer Histologies  Sai-Hong Ignatius Ou, MD,
Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,

Two Classic Lyrics Joined by a Contemporary Tune—Environmental Pro-Carcinogen Exposure and Genetic Susceptibility in Lung Cancer Risk  Ping Yang, MD,
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Primary non-Hodgkin’s lymphoma of the lung

Primary non-Hodgkin’s lymphoma of the lung
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.

Prognostic Significance of the Number of Lymph Nodes Removed at Lobectomy in Stage IA Non-small Cell Lung Cancer  Sai-Hong Ignatius Ou, MD, PhD, Jason.
The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors  Andrea L. Cheville, MD, MSCE,

The Value of a Symptom Cluster of Fatigue, Dyspnea, and Cough in Predicting Clinical Outcomes in Lung Cancer Survivors  Andrea L. Cheville, MD, MSCE,
Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer  Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.
Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,

Phase II Trial of Weekly Dose-Dense Paclitaxel in Extensive-Stage Small Cell Lung Cancer: Cancer and Leukemia Group B Study 39901  Stephen L. Graziano,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy  James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,

High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy  James R Headrick, MD, Francis C Nichols, MD, Daniel L Miller,
Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,

Salvage Resections for Recurrent or Persistent Cancer of the Proximal Esophagus After Chemoradiotherapy  Colin Schieman, MD, Dennis A. Wigle, MD, PhD,
Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer

Endpoints in Phase II Trials for Advanced Non-small Cell Lung Cancer
Fatigue, Dyspnea, and Cough Comprise a Persistent Symptom Cluster Up to Five Years After Diagnosis with Lung Cancer  Andrea L. Cheville, MD, MSCE, Paul.

Fatigue, Dyspnea, and Cough Comprise a Persistent Symptom Cluster Up to Five Years After Diagnosis with Lung Cancer  Andrea L. Cheville, MD, MSCE, Paul.
Trends in Subpopulations at High Risk for Lung Cancer

Trends in Subpopulations at High Risk for Lung Cancer

Similar presentations

Ads by Google